Efficient Robotics Launches a Commercial Fully-automated Microfluidic Platform Technology That Can Screen Millions of Biomolecules and Cells in One Day.
Revolutionizes the process of ultra-high throughput screening for the optimization of enzymes, antibodies, proteins, microbial strains and mammalian cells.
STUTTGART, Germany, DES MOINES, Iowa and SANTA BARBARA, California, May 29, 2019 /PRNewswire/ -- The global biotechnology research and development community now has a commercial breakthrough microfluidic platform that revolutionizes the process of ultra-high throughput screening for the optimization of enzymes, antibodies, proteins, microbial strains and mammalian cells. Efficient Robotics GmbH has announced the commercialization of its Nano-Titer-Pipe (NTP) Screening Workstation for screening and optimizing millions of biomolecules and cells in hours and days as opposed to conventional technologies, that takes weeks and even months... Please click here for the full PR-newswire article.
Microfluidics Stands on the Shoulders of Microfab Giants
Lab-on-a-chip industry adapts manufacturing technologies from other industries to rise quickly and gain perspective on the commercial opportunities ahead
New Microfluidic Screening Platform Introduced
Efficient Robotics recently introduced a microfluidic screening platform that enables the processing of microbial and mammalian cells, enzymes, proteins, antibodies and
peptides at an ultra-high-throughput of up to 10 million samples per day, according to Martin Mitchell, global marketing manager.